Patents Assigned to Tessa Therapeutics Ltd.
  • TREATMENT OF CD30-POSITIVE CANCER
    Publication number: 20230263890
    Abstract: Methods for treating a CD30-positive cancer in a subject are disclosed, wherein the methods comprise administering a lymphodepleting chemotherapy and CD30-specific chimeric antigen receptor (CAR)-expressing cells.
    Type: Application
    Filed: June 4, 2021
    Publication date: August 24, 2023
    Applicants: Tessa Therapeutics Ltd., The University of North Carolina at Chapel Hill
    Inventors: Aung Myo, Ivan David Horak, Jonathan Serody, Gianpietro Dotti, Barbara Savoldo
  • T Cell Expansion Method
    Publication number: 20200172864
    Abstract: The invention relates to the expansion of T cells and particularly, although not exclusively, to the expansion of gamma delta T cells, and the optimization of medium, serum and cytokine combinations for large-scale ex vivo expansion of gamma delta T cells for clinical use.
    Type: Application
    Filed: September 26, 2017
    Publication date: June 4, 2020
    Applicants: Tessa Therapeutics Ltd., Singapore Health Services Pte. Ltd.
    Inventors: Cheryl Lai-Lai CHIANG, Who-Whong WANG, Han Chong TOH